Comparison of Neuromuscular Recovery at the Hand and Foot - Trial NCT06236763
Access comprehensive clinical trial information for NCT06236763 through Pure Global AI's free database. This phase not specified trial is sponsored by Ciusss de L'Est de l'Île de Montréal and is currently Recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ciusss de L'Est de l'Île de Montréal
Timeline & Enrollment
N/A
Mar 01, 2024
Jul 01, 2024
Primary Outcome
Time of neuromuscular blockade (NMB) recovery
Summary
Gold standard for neuromuscular blockade evaluation is accelerometry in three dimensions at
 the thumb. There are many times that measurement at the hand can be falsely under-estimated
 intraoperatively secondary to constriction of the upper extremities. We believe that
 installing the same accelerometer at the first toe will give us similar readings for both
 neuromuscular blockade and recovery from rocuronium administration. This study focuses on
 agreement values between two accelerometers installed on the hand and at on the foot.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06236763
Device Trial